COO Research and Charts

COO - The Cooper Companies Inc (Healthcare: Medical Instruments & Supplies)

Projected Earnings Date: 2025-08-28 (Delayed quote data 2025-06-30)

Last 71.16	Change ⇑ +0.02 (+0.03%)	Volume 2,153,474
	Open 71.22	High 71.67	Low 70.58

8EMA (Daily) 70.44	40EMA (Daily) 74.03	50EMA (Daily) 75.17	STO (Daily) 48.437	MACD Hist (Daily) 0.856
8EMA (Weekly) 72.934	40EMA (Weekly) 84.30	50EMA (Weekly) 85.91	STO (Weekly) 26.450	MACD Hist (Weekly) -1.067


Company Profile
Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for approximately 75% of total sales, CooperVision is the the second- largest player in the oligopolistic contact lens market. Over 50% of CooperVision's sales are in international territories. The second unit, CooperSurgical, develops and manufactures diagnostic and surgical products for gynecologists and obstetricians, including the Paragard IUD, which Cooper acquired from Teva in 2017.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.